News
Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...
A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
From late 2020 to the summer of 2024, Eli Lilly ... in share price, however, investor sentiment for the next line of drugs front ran the stock price. For example, in 2016 Lilly was trading ...
The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets and beyond, leveraging the patent system, drug importation and more.
Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...
Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...
Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...
Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results